Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03423238 · ClinicalTrials.gov registry record · NA
Targeting Obesity to Optimize Health in Cardiac Rehab (TOPCARE)
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT03423238 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 38 participants.
The verdict
NCT03423238, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Although coronary heart disease (CHD) treatment guidelines recognize obesity as a major modifiable risk factor,2 nearly half of all CHD patients are obese and the current standard of care fails to implement evidence-based obesity treatment for this high-risk population. Multiple lines of evidence suggest that weight loss improves outcomes in CHD patients. The primary goal of this study is to determine the feasibility of adding a 6-month behavioral weight loss intervention to exercise-based cardiac rehabilitation.
Interventions
- OTHER Exercise
- BEHAVIORAL Health Education
- BEHAVIORAL Behavioral Modification
- OTHER Exercise Compliance
- DIETARY_SUPPLEMENT Calorie-Restricted Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2018-03-21 |
| Est. Completion | 2020-04-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03423238
The ClinicalTrials.gov registry entry for NCT03423238 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Exercise is the first listed.
NCT03423238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03423238 about?
NCT03423238 is a clinical study titled "Targeting Obesity to Optimize Health in Cardiac Rehab (TOPCARE)". Although coronary heart disease (CHD) treatment guidelines recognize obesity as a major modifiable risk factor,2 nearly half of all CHD patients are obese and the current standard of care fails to implement evidence-based obesity treatment for this high-risk population. Multiple lines of evidence su...
What is the current status of trial NCT03423238?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2018-03-21. Estimated completion is 2020-04-10.
What interventions are being tested in trial NCT03423238?
The interventions under investigation include: Exercise (OTHER), Health Education (BEHAVIORAL), Behavioral Modification (BEHAVIORAL), Exercise Compliance (OTHER), Calorie-Restricted Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03423238?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.